Focal lesions in the rat central nervous system induced by endothelin-1.
about
Oligodendrogenesis in the normal and pathological central nervous systemRodent models of focal stroke: size, mechanism, and purposeConsiderations for the Optimization of Induced White Matter Injury Preclinical ModelsModels that matter: white matter stroke modelsThe use of animal models for stroke research: a reviewAmeliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain InjuryCharacterisation of endothelin-1-induced intrastriatal lesions within the juvenile and adult rat brain using MRI and 31P MRS.CD200 restrains macrophage attack on oligodendrocyte precursors via toll-like receptor 4 downregulation.Acute astrocyte activation in brain detected by MRI: new insights into T(1) hypointensity.An Experimental Infarct Targeting the Internal Capsule: Histopathological and Ultrastructural Changes.Ribosomal S6 kinase regulates ischemia-induced progenitor cell proliferation in the adult mouse hippocampus.Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statinsThe axon-glia unit in white matter stroke: mechanisms of damage and recovery.Lasting pure-motor deficits after focal posterior internal capsule white-matter infarcts in rats.A white matter stroke model in the mouse: axonal damage, progenitor responses and MRI correlatesExperimental animal models and inflammatory cellular changes in cerebral ischemic and hemorrhagic stroke.The contribution of mannose binding lectin to reperfusion injury after ischemic stroke.Pediatric respiratory and systemic effects of chronic air pollution exposure: nose, lung, heart, and brain pathology.A Versatile Murine Model of Subcortical White Matter Stroke for the Study of Axonal Degeneration and White Matter NeurobiologyPhagocytosis executes delayed neuronal death after focal brain ischemia.Molecular and Cellular Responses to Interleukin-4 Treatment in a Rat Model of Transient Ischemia.Chemokines and neurodegeneration in the early stage of experimental ischemic stroke.Neurodegeneration and Glial Response after Acute Striatal Stroke: Histological Basis for Neuroprotective Studies.Experimental models for analysis of oligodendrocyte pathophysiology in stroke.Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.Animal models of ischemic stroke and their application in clinical researchProspects of modeling poststroke epileptogenesis.Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme.Diabetic aggravation of stroke and animal models.Neurogenesis associated with endothelin-induced cortical infarction in the mouse.Axonal protection achieved by blockade of sodium/calcium exchange in a new model of ischemia in vivoToll-like Receptor 2: A Novel Therapeutic Target for Ischemic White Matter Injury and Oligodendrocyte Death.Induced Pluripotent Stem Cell-Derived Neural Stem Cell Therapy Enhances Recovery in an Ischemic Stroke Pig Model.Mouse model of focal cerebral ischemia using endothelin-1.A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses.Diffuse axonal damage, myelin impairment, astrocytosis and inflammatory response following microinjections of NMDA into the rat striatum.Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment.
P2860
Q21129352-9EE8CB54-32CD-4FE8-8C84-38230000A8DDQ24529165-0EC089CD-EEC1-44B8-ACE3-7632A6812ED9Q26796210-4DC9D150-C97B-4274-B039-E558BE859516Q26829657-1F2A3E32-59CE-4461-8DAC-96171A0780FAQ26852140-EB2AFDBB-C2FC-4429-85FB-8FEE112127C8Q30387426-C681133E-9607-45AD-BE7E-E7B8260DFB15Q30712052-B1450495-AA79-4F0E-B72D-BB9500D19705Q30737779-B2650B7E-4926-45DE-93E6-47500E37E393Q31127588-A3DC6EA7-3811-4B76-99BC-F808BC1C3A45Q33729688-0DD549ED-62CA-4904-B310-D15973CCBFC0Q34138270-E0A13DFC-6CEF-4D2B-B82F-F5B0E0B49AC4Q34264444-6F722B34-B83C-40CF-86F1-7476C4A356EBQ35984483-959F5B6D-E08A-48FF-BD90-140EF9496035Q36267248-7D0A177D-028A-4709-B0BE-2D82F354B474Q36420002-C6355304-DE0A-424B-AEA0-8613E6D44506Q36425620-CFCF3206-83A8-47F5-8926-D20BA1E80A01Q36439690-95F66D25-B200-4E63-BA53-A818D765E323Q36746486-CC94F991-91D4-4046-AB45-CB0CF27DAACCQ36790914-7F85B7DF-FD78-4329-BF3C-6858526489A7Q37255890-7F8A9BB1-F331-46FE-B905-660ADDD783D5Q37350621-751DF93D-DC8B-4A80-A3A6-E0293A8B1BC4Q37351594-F3D03D66-F39D-4E59-B815-3000BE1620A2Q37512682-E23A077A-FA3D-4CD3-8CD8-AE73179BE1FDQ37691262-B2D428C6-9414-47FC-B234-56AD8F6CEFE0Q38259551-5BDDF3DA-B5CC-44A5-B00D-6AEAF5385559Q38546471-794921C1-9B46-46BD-97E5-160C097D6EF0Q38906926-F2087C5D-1689-4103-9A71-86FCFE1ABE54Q39001865-C60523AF-0902-4255-9B0D-BCCF2E18DFFCQ39169261-02DC6821-6038-482D-914C-ACFDC54E656CQ40792683-8E27C947-462E-4433-B899-7B22B09D0717Q40819221-06007B5B-69B5-4080-83C7-4F7E10825E71Q41128526-B78FBC59-30C2-4A24-87A9-C985B90044B1Q41565192-0916DB07-FDFB-4CEC-88F0-D114190E31B4Q42139497-CCA17FD6-3457-480E-9F7B-E8FABA3B1493Q45227509-B92AA971-55CE-42F4-BF0E-E26A99BCD957Q46978822-957EC48A-193F-4362-BB4D-3F3DE664D200Q48457563-2F209A62-1AB4-422F-8DDB-98C9D83ACB76
P2860
Focal lesions in the rat central nervous system induced by endothelin-1.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Focal lesions in the rat central nervous system induced by endothelin-1.
@en
Focal lesions in the rat central nervous system induced by endothelin-1.
@nl
type
label
Focal lesions in the rat central nervous system induced by endothelin-1.
@en
Focal lesions in the rat central nervous system induced by endothelin-1.
@nl
prefLabel
Focal lesions in the rat central nervous system induced by endothelin-1.
@en
Focal lesions in the rat central nervous system induced by endothelin-1.
@nl
P2093
P2860
P356
P1476
Focal lesions in the rat central nervous system induced by endothelin-1.
@en
P2093
Rankine EL
P2860
P304
P356
10.1093/JNEN/62.12.1276
P577
2003-12-01T00:00:00Z